Sort
4,870 grants matching “glp 1”
GLP-1 analogue effects on food cues, stress, motivation for highly palatable foods, and weight
$697,726Ania Jastreboff · Yale University · R01 · FY2021 · DK
GLP-1 analogue effects on food cues, stress, motivation for highly palatable foods, and weight
$697,726Ania Jastreboff · Yale University · R01 · FY2023 · DK
GLP-1 analogue effects on food cues, stress, motivation for highly palatable foods, and weight
$697,726Ania Jastreboff · Yale University · R01 · FY2022 · DK
Large animal therapy studies
$696,911William A. Beltran · University Of Pennsylvania · R24 · FY2013 · EY
Comparative Effectiveness and Safety of Metabolic/Bariatric Surgery, GLP-1, and SGLT-2 Medications for Patients with Obesity and Type 2 Diabetes
$696,763David Eric Arterburn · Kaiser Foundation Research Institute · R01 · FY2024 · DK
Large animal therapy studies
$696,492William A. Beltran · University Of Pennsylvania · R24 · FY2014 · EY
Targeting GLP-1 receptor as a new chronotherapy against nondipping blood pressure in diabetes
$695,237Ming C Gong · University Of Kentucky · R01 · FY2023 · HL
Targeting GLP-1 receptor as a new chronotherapy against nondipping blood pressure in diabetes
$695,237Ming C Gong · University Of Kentucky · R01 · FY2025 · HL
Targeting GLP-1 receptor as a new chronotherapy against nondipping blood pressure in diabetes
$695,237Ming C Gong · University Of Kentucky · R01 · FY2022 · HL
Pharmacogenetics of the Response to GLP-1 in Mexican-Americans with Prediabetes
$694,913Absalon Dennis Gutierrez · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · DK
Increased Protein at Breakfast for Weight Management in Overweight Adolescents
$694,804Heather J Leidy · University Of Texas At Austin · R01 · FY2019 · DK
A new radiopharmaceutical for the treatment of metastatic bone cancer
$694,709Jaime Nmn Simon · Isotherapeutics Group, Llc · R44 · FY2013 · CA
In-Situ Gelling Protein Polymer Intravascular Embolic Agent for Hepatic Carcinoma
$694,475Hamid Ghandehari · Theratarget · R42 · FY2017 · CA
Glycemic and Weight Loss Effects of Semaglutide in Subjects After Spinal Cord Injury and Type 2 Diabetes
$694,221Marzieh Salehi · University Of Texas Hlth Science Center · R01 · FY2025 · DK
Preclinical development of OR-449, a novel targeted therapy for adrenocortical cancer
$693,171Scott McNear Thacher · Orphagen Pharmaceuticals · R44 · FY2022 · CA
Targeting pancreatic endocrine-exocrine signaling in cancer development with incretin mimetics
$693,075Mandar Deepak Muzumdar · Yale University · R01 · FY2025 · CA
Advancing ADPKD Treatment with GLP-1RA: A Study of Glucagon-Like Peptide-1 Receptor Agonists' Efficacy, Safety, and Mechanism
$692,934Kristen Lynn Nowak · University Of Colorado Denver · R01 · FY2024 · DK
Evaluation of the entero-insular (incretin) axis in cystic fibrosis-competitive renewal.
$692,825Andrea Bridget Kelly · Children'S Hosp Of Philadelphia · R01 · FY2020 · DK
EP055, a non-hormonal male contraceptive:IND-enabling studies
$692,614Michael G O'Rand · Eppin Pharma, Inc. · R44 · FY2021 · HD
The weight-independent effects of bariatric surgeries on islet cell function
$692,362Marzieh Salehi · Cedars-Sinai Medical Center · R01 · FY2016 · DK
Reduced Carbohydrate Diet Intervention for PCOS
$692,049Barbara A. Gower · University Of Alabama At Birmingham · R01 · FY2009 · HD
Optimizing the Safety of the Newer Diabetes Medications in Patients with Diabetes and Kidney Disease
$691,774Julie Paik · Brigham And Women'S Hospital · R01 · FY2025 · DK
Image-guided Bariatric Arterial Embolization (BAE) for the Treatment of Obesity
$690,951Dara L Kraitchman · Johns Hopkins University · R01 · FY2023 · DK
Effects of bimagrumab on body composition, insulin sensitivity, and bone in adults with obesity
$690,694Melanie Schorr Haines · Massachusetts General Hospital · R01 · FY2024 · DK
Glycemic and Weight Loss Effects of Semaglutide in Subjects After Spinal Cord Injury and Type 2 Diabetes
$690,638Marzieh Salehi · University Of Texas Hlth Science Center · R01 · FY2024 · DK